Russia has started producing CoviVac, its third vaccine against Covid-19, and will soon make it available for use in its regions, though phase three trials are still underway, officials said, according to Reuters.

“The third Russian vaccine is entering civilian circulation and will appear in the regions in the coming days,” the Science and Higher Education Ministry said in a statement.

The Chumakov Centre plans to produce up to 10 million doses of the vaccine a year, the ministry said. Science Minister Valery Falkov said that phase three trials of the vaccine had begun, the Interfax news agency reported.

Opinion

Editorial

Sustainable path?
Updated 13 Jun, 2026

Sustainable path?

The FY27 budget is the first clear signal that the government is ready to transition from stabilisation to growth.
Prioritising education
13 Jun, 2026

Prioritising education

THOUGH the improvement in the country’s literacy rate may be slight, as highlighted by the Economic Survey, it ...
Poverty’s rise
13 Jun, 2026

Poverty’s rise

AS attention turns to the government’s plans for the coming fiscal year, one set of figures deserves particular...
A difficult story
Updated 12 Jun, 2026

A difficult story

Unless productivity becomes the dominant target of economic policy, Pakistan will continue to oscillate between crises and fragile recovery.
Rough waters
12 Jun, 2026

Rough waters

AMONGST the key potential triggers for fresh conflict in South Asia is water. The Indian state is behaving in an...
Politicised football
12 Jun, 2026

Politicised football

ALMOST three-and-half years since Lionel Messi led Argentina to FIFA World Cup glory, the latest edition of...